Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial

BACKGROUND: Early detection and treatment of asymptomatic men with advanced and high-risk prostate cancer (PCa) may improve survival rates. OBJECTIVE: To determine outcomes for men diagnosed with advanced PCa following prostate-specific antigen (PSA) testing who were excluded from the ProtecT random...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur Urol
Main Authors: Johnston, Thomas J., Shaw, Greg L., Lamb, Alastair D., Parashar, Deepak, Greenberg, David, Xiong, Tengbin, Edwards, Alison L., Gnanapragasam, Vincent, Holding, Peter, Herbert, Phillipa, Davis, Michael, Mizielinsk, Elizabeth, Lane, J. Athene, Oxley, Jon, Robinson, Mary, Mason, Malcolm, Staffurth, John, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Kockelbergh, Roger, Kynaston, Howard, Prescott, Steve, Paul, Alan, Powell, Philip, Rosario, Derek, Rowe, Edward, Donovan, Jenny L., Hamdy, Freddie C., Neal, David E.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier Science 2017
Fag:
Platinum Priority – Prostate Cancer
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5289293/
https://ncbi.nlm.nih.gov/pubmed/27720537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2016.09.040
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker